The rise and fall of mood stabilizers

Australian and New Zealand Journal of Psychiatry

Volumn 41, Issue 10, 2007, Pages 779-783

  Malhi, Gin S ^a,b   Goodwin, Guy M ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; TRANQUILIZER; VALPROATE SEMISODIUM;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL TRIAL; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; ELECTROCONVULSIVE THERAPY; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MANIA; MOOD DISORDER; RECURRENT DISEASE; RISK REDUCTION; SHORT COURSE THERAPY;

ACUTE DISEASE; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSION; HUMANS; MOOD DISORDERS;

EID: 34548652929     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670701579132     Document Type: Editorial

References (29)

1. Russell, SJ and Browne, JL. (2005) Staying well with bipolar disorder. Aust N Z J Psychiatry, 39, pp. 187-193.
2. Frances, A., Docherty, J. and Kahn, D. (1996) Treatment of bipolar disorder. J Clin Psychiatry, 57, pp. 5-58.
3. Goldney, RD, Fisher, LJ, Grande, ED, Taylor, AW and Hawthorne, G. (2005) Bipolar I and II disorders in a random and representative Australian population. Aust N Z J Psychiatry, 39, pp. 726-729.
4. Malhi, GS, Mitchell, PB and Salim, S. (2003) Bipolar depression: management options. CNS Drugs, 17, pp. 19-25.
5. Malhi, GS, Berk, M. and Bourin, M. (2005) Atypical mood stabilisers: A 'typical' role for atypical antipsychotics. Acta Psychiatr Scand, 111, pp. 29-38.
6. Bowden, CL and Karren, NU. (2006) Anticonvulsants in bipolar disorder. Aust N Z J Psychiatry, 40, pp. 386-393.
7. Tohen, M., Sanger, T. and McElroy, SL (1999) Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry, 156, pp. 702-709.
8. Calabrese, JR, Keck Jr, P. and Macfadden, W. (2005) A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry, 162, pp. 1351-1360.
9. Bauer, MS and Mitchner, L. (2004) What is a "mood stabilizer"? An evidence-based response. Am J Psychiatry, 161, pp. 3-18.
10. Bhagwagar, Z. and Goodwin, GM. (2002) The role of lithium in the treatment of bipolar depression. Clin Neurosci Res, 2, pp. 222-227.
11. McGorry, P. (2005) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry, 39, pp. 1-30.
12. Berk, M., Dodd, S. and Malhi, GS. (2005) 'Bipolar missed states': The diagnosis and clinical salience of bipolar mixed states. Aust N Z J Psychiatry, 39, pp. 215-221.
13. Goldberg, JF, Kelley, ME, Rosenquist, KJ, Hsu, DJ, Filkowski, MM and Ghaemi, S Nassir (2007) Effectiveness of quetiapine in rapid cycling bipolar disorder: A preliminary study. J Affect Disord
14. Calabrese, JR, Woyshville, MJ, Kimmel, SE and Rapport, DJ. (1993) Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol, 13, pp. 280-283.
15. Calabrese, JR, Suppes, T. and Bowden, CL (2000) A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry, 61, pp. 841-850.
16. Muzina, DJ and Calabrese, JR. (2005) Maintenance therapies in bipolar disorder: Focus on randomised controlled studies. Aust N Z J Psychiatry, 39, pp. 652-661.
17. Maggs, R. (1963) Treatment of manic illness with lithium carbonate. Br J Psychiatry, 109, pp. 56-65.
18. Calabrese, JR. (1999) Lamotrigine and the treatment of bipolar disorder. Eur Neuropsychopharmacol, 9, p. S107.
19. Calabrese, JR, Shelton, M. and Rapport, D. (2005) A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry, 162, pp. 2152-2161.
20. Geddes, JR, Burgess, S., Hawton, K., Jamison, K. and Goodwin, GM. (2004) Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry, 161, pp. 217-222.
21. Cipriani, A., Pretty, H., Hawton, K. and Geddes, JR. (2005) Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials. Am J Psychiatry, 162, pp. 1805-1819.
22. Bowden, CL, Brugger, A. and Swann, AC (1994) Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA, 271, pp. 918-924.
23. Bowden, CL, Calabrese, JR and McElroy, SL (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry, 57, pp. 481-489.
24. Goodwin, GM, Bowden, CL and Calabrese, JR (2004) A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry, 65, pp. 432-441.
25. Amann, B., Grunze, H., Vieta, E. and Trimble, M. (2007) Antiepileptic drugs and mood stability. Clinical EEG Neurosci, 38, pp. 116-123.
26. Fountoulakis, KN, Vieta, E., Sanchez-Moreno, J., Kaprinis, SG, Goikolea, JM and Kaprinis, GS. (2005) Treatment guidelines for bipolar disorder: A critical review. J Affect Disord, 86, pp. 1-10.
27. Scherk, H., Pajonk, FG and Leucht, S. (2007) Second-generation antipsychotic agents in the treatment of acute mania. A systematic review and meta-analysis of randomised controlled studies. Arch Gen Psychiatry, 64, pp. 442-455.
28. Sachs, GS, Nirenberg, AA and Calabrese, JR (2007) Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med, 356:17, pp. 1771-1773.
29. Goodwin, GM and Consensus Group of the British Association for Psychopharmacology (2003) Evidence-based guidelines for treating bipolar disorder: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol, 17, pp. 149-173.